Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
4.800
-0.020 (-0.41%)
Nov 11, 2026, 4:08 PM HKT
HKG:1167 Market Cap
HKG:1167 has a market cap or net worth of 3.75 billion as of November 10, 2026. It is the 14,866th most valuable company in the world and the 668th biggest in Hong Kong. Its market cap has decreased by 30.47% in one year.
Market Cap
3.75B
Enterprise Value
2.00B
Revenue
852.85M
Global Rank
Country Rank
#668 Hong Kong
PE Ratio
6.27
ChartMarket Cap Chart
Since December 21, 2020, HKG:1167's market cap has decreased from 10.95B to 3.75B, a decrease of -65.72%. That is a compound annual growth rate of -16.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 3.75B | -25.10% |
| Dec 31, 2025 | 5.01B | 400.46% |
| Dec 31, 2024 | 1.00B | -65.05% |
| Dec 29, 2023 | 2.87B | -28.96% |
| Dec 30, 2022 | 4.03B | -63.93% |
| Dec 31, 2021 | 11.19B | 3.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LongBio Pharma (Suzhou) | 4.35B |
| Abbisko Cayman | 4.21B |
| Ocumension Therapeutics | 4.12B |
| Hanx Biopharmaceuticals (Wuhan) | 3.68B |
| Mirxes Holding Company | 3.66B |
| TenNor Therapeutics (Suzhou) | 3.45B |
| TransThera Sciences (Nanjing) | 3.29B |
| Qyuns Therapeutics | 3.20B |